Challenger Ltd (CGF)
Australian Securities Exchange · Australia · prices in AUD · close of 22 Oct 2026
Key indicators
| Last close | AUD 11.64 |
|---|---|
| 52-week range | 7.25 – 11.83 |
| Return, 1 month / 3 months | +12.4% / +11.5% |
| Return, 1 year / 3 years | +35.3% / +117.3% |
| Trend | Uptrend |
| RSI (14) | 74 |
| Volatility (1 year) | 32.6% |
| Worst drawdown (1 year) | -21.5% |
| Average daily value traded | 28.01M AUD |
| Dividend yield | 2.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Challenger Ltd is an Australian financial services company based in Sydney. It provides retirement income products, chiefly annuities that pay customers a regular income for life or for a set period, and it serves retirees and people planning for retirement in Australia. Through its funds management arm, the company also partners with boutique investment managers and offers investment strategies to institutional and retail investors. Its business centres on helping customers turn savings into dependable retirement income.
The shares are listed on the Australian Securities Exchange in Australia under the code CGF, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Challenger Ltd (CGF) trades on the Australian Securities Exchange in Australia. It last closed at AUD 11.64 on 22 October 2026.
Its price-based Market X-Ray is 85 out of 100 (a strong price profile), ranking 31 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 35.3% and over the last three months it rose 11.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 93 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 26.5% | ||
| From 52-week high | -0.9% | ||
| Momentum | 85 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 11.5% | ||
| 6-month return | 42.7% | ||
| 12-month return, skipping the last month | 20.4% | ||
| Stability (higher is calmer) | 88 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 32.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.5% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 28.01M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 39 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.8% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +20.6% |
|---|---|
| 1 month | +12.4% |
| 3 months | +11.5% |
| 6 months | +42.7% |
| 1 year | +35.3% |
| 3 years | +117.3% |
| 5 years | +101.0% |
Signals
| 50-day / 200-day average | 10.04 / 9.20 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.33 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Aug 2026 | AUD 0.1750 |
| 24 Feb 2026 | AUD 0.1550 |
| 26 Aug 2025 | AUD 0.1500 |
| 25 Feb 2025 | AUD 0.1450 |
| 26 Aug 2024 | AUD 0.1350 |
| 20 Feb 2024 | AUD 0.1300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.